Literature DB >> 25529521

Congenital cardiac anomalies in myelomeningocele patients.

Iman Moeini Naghani1, Taraneh Hashemi Zonouz1, Shima Shahjouei1, Amir Azar Homayoun2, Farideh Nejat3, Mostafa El Khashab4.   

Abstract

OBJECTIVE: Myelomeningocele may be isolated but more frequently is associated with other anomalies. Congenital heart disease occurs with different incidence rate in myelomeningocele which is observed more frequently with skeletal malformations.
METHODS: This study was undertaken in the Children's Hospital Medical Center between 2010 to 2012 to evaluate 75 myelomeningocele patients for cardiac anomalies, with electrocardiography and echocardiography in addition to clinical examination of the cardiopulmonary system. Demographic information, myelomeningocele location and characteristics, orthopedic deformities, neurological deficits and radiographic findings were studied besides cardiologic assessments.
RESULTS: The ages of the patients ranged from 1 day to 4 years. The myelomeningocele locations were lumbosacral, lumbar and sacral area in most cases. Physical examination of the heart was abnormal in 6 children, but echocardiography revealed cardiac anomalies in only two children. Both children were female patients with severe scoliosis, multiple rib deficiencies and associated vertebral anomalies.
CONCLUSION: Congenital heart defects are not very common in MMC patients. Female patients with suspicious clinical examinations for cardiac anomalies and associated rib and vertebral anomalies are advised to be investigated by echocardiography to rule out associated cardiac anomalies.
Copyright © 2014 by Academy of Sciences and Arts of Bosnia and Herzegovina.

Entities:  

Mesh:

Year:  2014        PMID: 25529521     DOI: 10.5644/ama2006-124.115

Source DB:  PubMed          Journal:  Acta Med Acad        ISSN: 1840-1848


  1 in total

1.  Congenital Heart Disease and Myelomeningocele in the Newborn: Prevalence and Mortality.

Authors:  J Kevin Wilkes; William E Whitehead; Yunfei Wang; Shaine A Morris
Journal:  Pediatr Cardiol       Date:  2021-03-10       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.